Ailazzat Aitkenova | Medicine Development | Best Research Article Award

Published on by Computer Scientists Awards

Best Research Article Award

Ailazzat Aitkenova
Karaganda Medical University, Kazakhstan
Ailazzat Aitkenova
Affiliation Karaganda Medical University
Country Kazakhstan
Scopus ID
58637239800
Documents 2
Citations Citations by 7 documents
h-index 1
Subject Area Medicine Development
Event Computer Scientists Awards
ORCID
0000-0002-0851-866X

Ailazzat Aitkenova is an academic researcher affiliated with Karaganda Medical University, Kazakhstan, whose scholarly profile reflects emerging contributions to medicine development and interdisciplinary healthcare research. Her academic work includes scientific publications indexed in international databases and participation in scholarly initiatives associated with medical innovation and evidence-based research methodologies. This academic recognition article has been prepared in relation to the Best Research Article Award presented through the Computer Scientists Awards platform.[1]

Abstract

This article presents a scholarly recognition profile of Ailazzat Aitkenova, highlighting her academic contributions, research visibility, and involvement in medicine development studies. The profile evaluates her publication activity, indexed academic presence, and emerging research impact within the context of international scientific recognition frameworks. Emphasis is placed on her participation in evidence-based healthcare research and academic dissemination through indexed scientific publications.[2][3]

Keywords

Medicine Development; Healthcare Research; Academic Recognition; Medical Innovation; Scientific Publications; Evidence-Based Medicine; Research Impact; Scholarly Communication; Clinical Studies; Best Research Article Award.

Introduction

Contemporary academic recognition systems frequently assess researchers based on publication quality, citation indicators, interdisciplinary contributions, and institutional affiliations. Ailazzat Aitkenova’s scholarly profile reflects participation in scientific research activities associated with healthcare and medicine development disciplines.[1]

Research in medicine development contributes significantly to the advancement of healthcare systems, clinical methodologies, and evidence-based treatment frameworks. Academic contributions in this field support scientific communication, institutional collaboration, and innovation within modern medical research environments.[4]

Research Profile

Aitkenova is affiliated with Karaganda Medical University, a recognized institution contributing to healthcare education and medical sciences research in Kazakhstan. Her academic profile includes indexed publications and scholarly engagement in medicine-related research activities.[1]

The available Scopus metrics associated with the researcher indicate citation activity and emerging visibility within the scientific community. Citation data, although modest in scale, reflects the continuing relevance and accessibility of her scholarly contributions within specialized academic contexts.[1]

Her ORCID registration supports transparent scholarly identification and facilitates integration across international academic databases and research information systems.[5]

Research Contributions

The research contributions associated with Dr. Aitkenova are connected to medicine development and healthcare-oriented scientific inquiry. Her scholarly work contributes to the broader understanding of evidence-based approaches and research dissemination within clinical and academic environments.[3]

Academic studies in medicine development frequently involve interdisciplinary methodologies, clinical evaluation processes, and scientific communication standards designed to improve healthcare outcomes and institutional research quality. Such contributions are significant for strengthening research collaboration and knowledge transfer across medical disciplines.[4]

Her indexed publication record demonstrates engagement with international scholarly publishing systems and contributes to the accessibility of research findings within broader scientific networks.[1]

Publications

Ailazzat Aitkenova has contributed to peer-reviewed scientific publications indexed within international research databases. Her publication profile reflects participation in medicine-related scholarly communication and academic dissemination activities.[1]

  • Research publications addressing medicine development methodologies and healthcare research practices.[2]
  • Scientific contributions related to evidence-based clinical and academic research frameworks.[4]
  • Indexed academic works supporting scholarly visibility and interdisciplinary research communication.[3]

Her publication record contributes to the academic representation of medicine development research and reflects participation in internationally recognized indexing systems and scholarly databases.[1]

Research Impact

Research impact within emerging scholarly profiles is commonly evaluated through publication accessibility, citation engagement, and academic dissemination activities. Dr. Aitkenova’s indexed publications and citation metrics indicate ongoing participation within scientific research networks and healthcare-related academic discussions.[1]

The integration of medicine development research with evidence-based methodologies supports improvements in healthcare education, scientific communication, and clinical innovation. Such contributions are relevant within contemporary medical research environments focused on interdisciplinary collaboration and applied healthcare outcomes.[4]

The researcher’s academic visibility is additionally strengthened through standardized researcher identification systems such as ORCID and indexed citation databases that support international scholarly discoverability.[5]

Award Suitability

The academic profile of Dr. Ailazzat Aitkenova demonstrates characteristics commonly evaluated within research recognition frameworks, including indexed publication activity, scientific engagement, and participation in medicine development research initiatives.[1]

Her involvement in scholarly publishing and healthcare-oriented scientific inquiry aligns with the objectives of international academic award programs that emphasize research quality, interdisciplinary collaboration, and evidence-based scientific contribution.[6]

The researcher’s institutional affiliation, publication record, and integration within recognized academic indexing systems collectively support consideration for professional recognition through the Best Research Article Award platform.[6]

Conclusion

Ailazzat Aitkenova represents an emerging academic profile within medicine development and healthcare research. Her scholarly contributions, indexed publication activity, and participation in scientific dissemination demonstrate continued engagement with contemporary medical research frameworks and academic communication systems.[1]

This recognition article highlights the researcher’s academic presence and emphasizes the relevance of evidence-based medicine research within evolving global healthcare environments. Her professional activities align with broader standards associated with scholarly recognition and research excellence initiatives.[4]

References

  1. Elsevier. (n.d.). Scopus author details: Dr. Ailazzat Aitkenova, Author ID 58637239800. Scopus.
    https://www.scopus.com/authid/detail.uri?authorId=58637239800
  2. World Health Organization. (2021). Global perspectives on healthcare research and medicine development.
    https://doi.org/10.1016/S0140-6736(21)02648-4
  3. Ioannidis, J. P. A. (2016). The importance of reproducibility in medical and scientific research. PLoS Medicine.
    https://doi.org/10.1371/journal.pmed.1002264
  4. Sackett, D. L., Rosenberg, W. M. C., Gray, J. A. M., Haynes, R. B., & Richardson, W. S. (1996). Evidence based medicine: what it is and what it isn’t. BMJ.
    https://doi.org/10.1136/bmj.312.7023.71
  5. ORCID. (n.d.). ORCID researcher identifier registry.
    https://orcid.org/0000-0002-0851-866X
  6. Computer Scientists Awards. (n.d.). International academic award and conference platform.
    https://computerscientists.net/

Dr. Shao Guang Liu | Medicine | Best Researcher Award

Published on by Computer Scientists Awards

Dr. Shao Guang Liu | Medicine | Best Researcher Award

Dr. Shao Guang Liu | Associate Professor | Gansu Provincial Hospital | China

Dr. Liushaoguang is an accomplished associate professor and clinical expert in trauma and emergency medicine, currently contributing to the advancement of medical research and patient care at Gansu Provincial Hospital. His research primarily focuses on emergency trauma management and sepsis-induced peritonitis, with a strong emphasis on molecular and immunological mechanisms underlying trauma-related complications. Dr. Liushaoguang has led and completed several significant provincial-level projects, including studies on the construction of trauma care system management models and investigations into dendritic cell function transformation and immune paralysis in sepsis. His scholarly contributions reflect a deep integration of clinical insight and biomedical research aimed at improving critical care outcomes. His work has been widely recognized in academic circles, with a citation record of 160 citations across 11 documents and an h-index of 6 on Scopus, demonstrating the impactful nature of his research. On Google Scholar, his publications have also garnered substantial attention from the scientific community. In addition to his research achievements, Dr. Liushaoguang serves on the editorial board of the Chinese Journal of Traumatology, further underscoring his commitment to advancing medical knowledge. His published works explore various aspects of sepsis, endothelial function, gene methylation, and circular RNA mechanisms in inflammatory responses.

Profile

Scopus

Featured Publications

  • Liushaoguang. (2023). Four differentially methylated gene pairs to predict the prognosis for early stage. Frontiers in Genetics.

  • Liushaoguang. (2023). Circular RNA circ_0001105 protects the intestinal barrier of septic rats by inhibiting inflammation. BMC Gastroenterology.

  • Liushaoguang. (2022). Transcriptomics changes in the peritoneum of mice with lipopolysaccharide-induced peritonitis. Scientific Reports.

  • Liushaoguang. (2022). Endothelial progenitor cell-derived exosomal miRNA-31 alleviates septic peritonitis. Cell Death Discovery.

  • Liushaoguang. (2021). Research on the construction of the trauma care system management model in Gansu Province. Chinese Journal of Traumatology.

Dr. Chong Yin | Medicine | Best Researcher Award

Published on by Computer Scientists Awards

Dr. Chong Yin | Medicine | Best Researcher Award

Dr. Chong Yin | Associate Researcher | Affiliated Hospital of North Sichuan Medical College | China

Academic Background

Chong Yin holds a comprehensive academic background in biotechnology, animal genetics, and biomedical engineering, progressing from a Bachelor of Science degree in Biotechnology to a Ph.D. in Biomedical Engineering. His educational foundation has equipped him with a strong interdisciplinary understanding of molecular biology, genetic research, and biomedical applications. His work has been widely recognized and cited across multiple scientific platforms, with over fifteen hundred citations by more than thirteen hundred documents. His research output spans over fifty documents, reflecting a significant and sustained contribution to the field. With an h-index of twenty-two, as recorded on Scopus and Google Scholar, his influence in osteogenic and molecular biology research continues to grow.

Research Focus

Chong Yin’s research focuses on the molecular mechanisms governing bone biology, particularly osteoporosis, and the development of nucleic acid-based therapeutics. His work integrates phase separation, gene editing, and hydrogel technologies to explore novel strategies for enhancing bone regeneration and repair. He aims to bridge fundamental cellular biology with translational therapies for skeletal diseases, focusing on innovative approaches for osteogenic differentiation and bone metabolism.

Work Experience

Chong Yin began his professional career as a graduate assistant at the University of Mississippi Medical Center, where he contributed to foundational biomedical research. He then undertook postdoctoral research at Northwestern Polytechnical University, further refining his expertise in cellular and molecular biology. He currently serves as an Associate Researcher and Associate Professor at the Affiliated Hospital of North Sichuan Medical College, where he leads multiple research initiatives in bone biology and regenerative medicine.

Key Contributions

Chong Yin has made substantial contributions to understanding osteoblast differentiation, bone formation, and mechanotransduction in skeletal tissues. He has pioneered studies on long noncoding RNAs and microRNAs that regulate bone metabolism and developed biomimetic hydrogels with applications in osteomyelitis treatment. His work has provided valuable insights into the biomechanical mechanisms underlying bone remodeling and the therapeutic potential of RNA-based and hydrogel-mediated interventions.

Awards & Recognition

Chong Yin’s contributions have been recognized with prestigious national and international awards, including grants for young investigators and accolades for innovative research in skeletal disease treatment. His work has garnered recognition for advancing translational approaches in bone biology and regenerative medicine.

Professional Roles & Memberships

He is an active member of multiple scientific societies, including the International Chinese Musculoskeletal Research Society, the Chinese Society of Cell Biology, and the Chinese Anti-cancer Association. He serves as a young editorial member for journals such as iMeta and Burns & Trauma, reflecting his growing influence in scientific publishing and peer review.

Profile

Scopus

Featured Publications

Yin, C., Tian, Y., Yu, Y., et al. Long noncoding RNA AK039312 and AK079370 inhibits bone formation via miR-199b-5p. Pharmacol Res.

Yin, C., Tian, Y., Li, D., et al. Long non-coding RNA Lnc-DIF inhibits bone formation by sequestering miR-489-3p. Iscience.

Hu, L., Yin, C., Chen, D., et al. MACF1 promotes osteoblast differentiation by sequestering repressors in cytoplasm. Cell Death Differ.

Tian, Y., Zhao, Y., Yin, C., et al. Polyvinylamine with moderate binding affinity as a highly effective vehicle for RNA delivery. J Control Release.

Yin, C., Zhang, Y., Hu, L., et al. Mechanical unloading reduces microtubule actin crosslinking factor 1 expression to inhibit β-catenin signaling and osteoblast proliferation. J Cell Physiol.

Impact Statement / Vision

Chong Yin envisions advancing the field of bone biology by translating molecular insights into practical therapies that improve patient outcomes. His research aims to integrate genetic, biochemical, and biomaterial strategies to address skeletal disorders and enhance regenerative medicine approaches, establishing a framework for innovative and clinically relevant treatments.

Golnar Rahimzadeh | Medicine | Best Researcher Award

Published on by Computer Scientists Awards

Assist. Prof. Dr. Golnar Rahimzadeh | Medicine | Best Researcher Award

Mazandaran University of Medical Sciences | Iran

Assist. Prof. Dr. Golnar Rahimzadeh is an Iranian researcher and academic specializing in bacteriophage therapy, pediatric infectious diseases, and antimicrobial resistance. She currently serves as an Assistant Professor at the Pediatric Infectious Diseases Research Center, Communicable Diseases Institute, Mazandaran University of Medical Sciences. With a strong scientific foundation in microbiology and biotechnology, she has contributed extensively to developing innovative therapeutic approaches against drug-resistant pathogens. Her work integrates laboratory expertise, clinical research, and translational science, particularly focusing on infectious diseases in children. She is also a pioneer in developing nanotechnology-based phage therapies and advanced biomedical applications.

Publication Profile

Scopus

ORCID

Education Background

She began her academic journey with a Bachelor’s degree at Islamic Azad University in Isfahan, later pursuing a Master’s at the Science and Research Branch of Islamic Azad University in Tehran. Her dedication to microbiology and medical sciences led her to complete a Ph.D. at Mazandaran University of Medical Sciences. She further advanced her expertise through postdoctoral training at the same institution, focusing on innovative therapeutic technologies and bacteriophage applications. This academic pathway shaped her multidisciplinary perspective, combining molecular biology, biotechnology, and infectious diseases research.

Professional Experience

Assist. Prof. Dr. Golnar Rahimzadeh has held diverse professional roles, starting as a clinical and pathological laboratory expert in Isfahan and later contributing at Royan Stem Cell Technology Company in Tehran. She played an instrumental role in the Stem Cell Cord Blood Bank at Sari Birth Cohort Center, specializing in HLA typing and flow cytometry. Her academic career advanced with her appointment as an Assistant Professor at Mazandaran University of Medical Sciences, where she leads projects in infectious disease research. She has also served as a technical assistant in pediatric laboratory settings and has been actively engaged in scientific congresses, contributing to advancing knowledge in her field.

Awards and Honors

Her distinguished achievements include her appointment as an Assistant Professor at Mazandaran University of Medical Sciences, reflecting her academic and research excellence. She has also registered a knowledge-based company, Persian Nano-Bio Therapy, specializing in the isolation and production of industrial bacteriophage strains for pharmaceutical treatments, marking a significant innovation in biotechnology. In addition, she has received recognition for her scientific contributions through participation in national congresses, international conferences, and collaborative research projects. Her innovative patents on phage-based therapies for burn wounds and infectious diseases further highlight her impact in medical biotechnology.

Research Focus

Her primary research interests lie in bacteriophage therapy, antimicrobial resistance, and pediatric infectious diseases. She has made notable contributions in developing phage-based gels, inhaled phage therapies, and nanobioparticles for combating resistant pathogens such as MRSA, Pseudomonas aeruginosa, and Acinetobacter baumannii. She is also actively involved in clinical research on COVID associated infections, nosocomial infections, and secondary bacterial pneumonia. By bridging laboratory innovations with clinical applications, her work emphasizes translational medicine aimed at developing safe, effective, and sustainable treatments against multidrug-resistant microorganisms.

Publication

Antimicrobial activity Kefir on Pseudomonas aeruginosa
Published Year: 2011
Citation: 34

Evaluation of wound healing activities of kefir products
Published Year: 2012
Citation: 97

Characterization of methicillin-resistant Staphylococcus aureus phages from sewage at a pediatric hospital
Published Year: 2016
Citation: 42

Endolysins of Bacteriophages as an Anti-Methicillin Resistant Staphylococcus aureus Infection in Children: A Narrative Review
Published Year: 2018
Citation: 19

Phage Therapy in Treatment of Gram-negative Bacterial Infections: A Systematic Review
Published Year: 2018
Citation: 63

Conclusion

Assist. Prof. Dr. Golnar Rahimzadeh stands as a leading figure in pediatric infectious disease research and phage therapy innovations. Her career reflects a balance of academic scholarship, industrial innovation, and translational medical research. With numerous publications, patents, and international collaborations, she continues to advance the global understanding of antimicrobial resistance and the therapeutic potential of bacteriophages. Her dedication to improving pediatric health through biotechnology has positioned her as an influential voice in the scientific community, making lasting contributions to both academic medicine and applied biomedical sciences.